TOKYO -- Teva Takeda Pharma is increasing overseas production of generic medication to cut billions of yen in costs per year as drug prices continue to decline.
The joint venture of Takeda Pharmaceutical and Teva Pharmaceutical Industry currently produces roughly 5% of its drugs overseas.
